IBB

iShares NASDAQ Biotechnology ETF
A

74
*Unless otherwise stated, data provided by FactSet.

IBB Fund Description

IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

IBB Factset Analytics Insight

The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.

IBB MSCI ESG Analytics Insight

iShares NASDAQ Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 3.94 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares NASDAQ Biotechnology ETF ranks in the 19th percentile within its peer group and in the 31st percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IBB MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

IBB CHARTS AND PERFORMANCE

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 08/15/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IBB -2.36% 0.65% 6.92% -12.01% 2.06% 3.59% 15.24%
IBB (NAV) -3.16% -0.47% 6.20% -10.70% 1.65% 3.36% 15.23%
NASDAQ Biotechnology Index -3.16% -0.41% 6.41% -10.44% 1.97% 3.66% 15.23%
Thomson Reuters US Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IBB Summary Data

Blackrock
iShares
02/05/01
Open-Ended Fund
0.47%
$6.87B
$233.91M
0.03%

IBB Portfolio Data

$34.62B
-885.61
5.15
0.11%
09/24/19
221

IBB Index Data

Market Cap
NASDAQ - Listed
Thomson Reuters US Biotechnology & Medical Research

IBB Portfolio Management

0.47%
-0.31%
-0.24%
-2.42%

IBB Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IBB Fund Structure

Open-Ended Fund
No
Yes
72% / 29%
N/A
N/A
Low
Daily
Cboe Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

IBB Factset Analytics Block Liquidity

As of 08/16/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBB. IBB is rated a 5 out of 5.

IBB Tradability

2,201,156
$233.91M
1,962,002
$211.40M
0.03%
$0.04
-0.01%
0.54% / -0.42%
None
100.00%
50,000
39.24
0.01%
0.11%
234,890
$102.76
5

IBB Sector/Industry Breakdown


IBB
Segment Benchmark
39.56%
57.45%
19.45%
40.39%
18.82%
--
10.81%
--
7.15%
--
1.48%
--
0.78%
--
0.58%
2.16%
0.53%
--
0.27%
--

IBB Countries


IBB
Segment Benchmark
95.83%
100.00%
0.83%
--
0.81%
--
0.71%
--
0.66%
--
0.40%
--
0.37%
--
0.15%
--
0.10%
--
0.08%
--

IBB Regions


IBB
Segment Benchmark
95.91%
100.00%
3.33%
--
0.76%
--

IBB Economic Development


IBB
Segment Benchmark
99.90%
100.00%
0.10%
--

IBB Performance Statistics

0.94
0.91
0.87
0.95
0.41%
Thomson Reuters US Biotechnology & Medical Research

IBB MSCI ESG Ratings

BB
3.94 / 10
31.11
19.24
0.16%
36.13%
23.77

IBB BENCHMARK COMPARISON HOLDINGS

221
141
121
53.85%

IBB BENCHMARK COMPARISON SUMMARY


IBB
Segment Benchmark
221
141
$34.62B
$28.46B
-885.61
-145.67
5.15
5.27
0.53%
0.67%
Medium
High

IBB BENCHMARK COMPARISON MARKET CAP SIZE


IBB
Segment Benchmark
52.44%
48.64%
28.54%
30.60%
15.94%
18.28%
2.98%
2.47%

Options Strategies for Outcome Investing

Options allow you to customize investment outcomes. Using the strategy builders provided by Cboe Vest Technologies, you can construct some of the most common option strategies. Check out our user guide for more information on how to use the tool.

A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.